News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

March 1, 2022 signalgroup

Biosimilars Forum Welcomes HHS Inspector General Study on Biosimilars in Medicare Part B

February 22, 2022 signalgroup

Report Highlights Employer Savings from Increased Employee Access to Biosimilars

February 15, 2022 signalgroup

The Biosimilars Forum Congratulates Dr. Robert Califf on His Confirmation as FDA Commissioner

February 3, 2022 signalgroup

Biosimilars Forum Supports the Negotiated BsUFA III Agreement in Capitol Hill Testimony

January 31, 2022 signalgroup

Juliana M. Reed Named Executive Director of the Biosimilars Forum

November 12, 2021 Katie Quinn

The Biosimilars Forum Congratulates Robert Califf on His Nomination for FDA Commissioner

October 26, 2021 Katie Quinn

Biosimilars Forum to Congress: Incentivize Biosimilars in Build Back Better Act

October 21, 2021 signalgroup

Biosimilars Forum Member Spotlight: 5 Questions for Samsung Bioepis

October 20, 2021 signalgroup

First Biosimilar to Treat Eye Disease Gains FDA Approval

October 20, 2021 Katie Quinn

Biosimilars Forum Applauds FDA’s Approval of Second Interchangeable Biosimilar